Page 6 - Global Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED May 03, 2026

Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

3,013 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
AURX	US$1.15	-11.5%	-27.7%	US$55.7m	US$3.00	16.8	71.3%	n/a
FBIO	US$2.33	0%	27.3%	US$75.0m	US$10.75	1.2	70.9%	n/a
BOT	AU$0.027	-18.2%	-94.1%	AU$73.4m	n/a	3.4	70.8%	n/a
CAI	US$18.47	-8.6%	n/a	US$5.2b	US$29.69	6.4	70.5%	n/a
ETST	US$0.14	-3.3%	-2.6%	US$40.8m	US$1.00	11.6	70.5%	n/a
DB	CA$0.13	-3.8%	78.6%	CA$72.1m	n/a	1.2	70.3%	n/a
A0009K0	₩46,850.00	-6.7%	n/a	₩3.0t	n/a	603.2	70.1%	n/a
2929	JP¥637.00	-2.5%	-30.5%	JP¥18.5b	n/a	1.9	69.8%	3.9%
SRRA	US$54.99	0.06%	179.4%	US$1.3b	US$55.00	5.1	69.5%	n/a
TLSI	US$4.39	-5.4%	-14.1%	US$269.6m	US$9.20	6.0	69.5%	n/a
RNXT	US$0.88	3.1%	-11.7%	US$39.8m	US$6.88	35.4	69.3%	n/a
EDT	CA$1.36	-2.9%	63.9%	CA$399.0m	CA$3.15	163.4	69.2%	n/a
PGEN	US$4.08	-1.2%	159.9%	US$1.4b	US$9.50	149.1	68.4%	n/a
NERV	US$6.07	-7.7%	257.1%	US$266.1m	US$9.50	-0.9	68.3%	n/a
A042520	₩29,400.00	-2.6%	300.0%	₩419.3b	n/a	4.2	68.1%	0%
RARE	US$24.77	2.8%	-37.0%	US$2.4b	US$53.35	3.6	68.0%	n/a
MAAT	€5.85	7.1%	-0.2%	€110.2m	€16.00	24.4	68.0%	n/a
OCGN	US$1.80	8.4%	135.3%	US$609.3m	US$11.57	138.1	67.8%	n/a
IOVA	US$3.40	-1.2%	-2.9%	US$1.4b	US$9.00	5.3	67.7%	n/a
ANIK	US$14.85	-3.4%	0%	US$199.0m	US$17.50	1.7	67.6%	n/a
QNCX	US$1.33	-2.2%	-87.5%	US$21.7m	n/a	-0.3	67.2%	n/a
CANF	₪4.59	-5.2%	-89.8%	₪19.7m	n/a	16.5	66.8%	n/a
MDCX	US$0.29	-9.4%	-93.5%	US$11.2m	US$6.50	-0.2	66.1%	n/a
CRDL	CA$1.84	-2.6%	16.5%	CA$205.8m	CA$6.00	11.5	66.0%	n/a

Page 6 of 126